多头涌入？港股通创新药ETF（520880）午后直线拉升！近10日大举吸金逾2亿元

Core Viewpoint - The Hong Kong Stock Connect Innovation Drug ETF (520880) experienced a significant price surge, indicating strong buying interest, particularly in the context of the upcoming Federal Reserve interest rate decision [1][3]. Group 1: Market Activity - The ETF saw a net subscription of 33.18 million yuan yesterday, bringing the total inflow over the past 10 trading days to over 210 million yuan [3]. - The ETF's price reflects a clear battle between bulls and bears, especially as the Hong Kong market was closed for the Chung Yeung Festival [1]. Group 2: ETF Characteristics - The Hong Kong Stock Connect Innovation Drug ETF (520880) passively tracks the Hang Seng Hong Kong Stock Connect Innovation Drug Select Index, which exclusively includes innovative drug development companies and has over 70% of its holdings in large-cap innovative drug leaders [3][4]. - The top ten holdings account for 71.63% of the index, showcasing a significant concentration in leading companies [4]. Group 3: Performance Metrics - The Hang Seng Hong Kong Stock Connect Innovation Drug Select Index has shown a year-to-date increase of 108.14%, outperforming other innovative drug indices [4][5]. - The ETF has a total fund size of 1.806 billion yuan and an average daily trading volume of 493 million yuan since its inception, making it the largest and most liquid ETF in its category [5].